Searchable abstracts of presentations at key conferences in endocrinology

ea0038oc6.5 | Advances in reproduction and signalling | SFEBES2015

Pituitary tumor transforming gene binding factor (PBF): a novel modulator of iodide uptake and target for Src phosphorylation in breast cancer

Poole Vikki , Fletcher Alice , Modasia Bhavika , Sharma Neil , Thompson Rebecca , Imruetaicharoenchoke Waraporn , Read Martin , Boelaert Kristien , Smith Vicki , McCabe Christopher

Although the sodium iodide symporter (NIS) is expressed in 70–80% of breast cancers, only 20–30% is located at the plasma membrane (PM) and therefore functional. Previous work in thyroid cells leads demonstrated that PBF redistributes NIS from the PM into intracellular vesicles, potently reducing radioiodide uptake. We therefore examined whether increased membranous NIS could facilitate radioiodide therapy for breast cancer. Immunofluorescent microscopy revealed co-l...

ea0038fp12 | (1) | SFEBES2015

Characterising the functional significance of the first reported mutations in the pituitary tumor-transforming gene binding factor

Imruetaicharoenchoke Waraporn , Watkins Rachel , Modasia Bhavika , Poole Vikki , Fletcher Alice , Thompson Rebecca , Boelaert Kristien , Smith Vicki , Read Martin , McCabe Christopher

Pituitary tumor-transforming gene binding factor (PBF) is a ubiquitous glycoprotein which is over-expressed in thyroid, breast and other endocrine cancers, and modulates cellular invasion, radioiodine uptake and thyroid hormone efflux. Papillary thyroid cancer patients with high PBF expression show decreased disease-specific survival compared to those with lower expression. PBF expression has recently been correlated with breast cancer metastasis and colon cancer extra-mural v...

ea0038p394 | Steroids | SFEBES2015

Synthetic glucocorticoid (GC) treatment induces prolonged activation of GC receptors in discrete brain regions and impairs memory and learning processes in the rat

Birnie Matthew , Demski-Allen Rebecca , Flynn Ben , Kershaw Yvonne , Barker Gareth , Warburton Clea , Lightman Stafford , Conway-Campbell Becky

Chronic treatment with the synthetic glucocorticoid (GC) prednisolone has been reported in association with many detrimental health effects. In addition to well-documented adverse metabolic effects, there is evidence for memory impairments in these patients. GCs are known to have effects on memory, either enhancing or impairing dependant upon timing of exposure. Cell experiments have shown that synthetic GCs such as methyl-prednisolone (MPL) cause an alteration in timing of gl...

ea0070aep130 | Bone and Calcium | ECE2020

Phase II study of the impact of AZD4017, a selective 11β-HSD1 inhibitor, on osteocalcin in post-menopausal osteopenia

Abbas Afroze , Eastell Richard , K Crowley Rachel , Ainsworth Gemma , Brown Sarah , Flanagan Louise M , Fairclough Rebecca J , Stewart Paul M

The causative link between circulating glucocorticoid excess and osteoporosis is established. Although circulating cortisol levels do not change significantly with age, local tissue metabolism may be implicated in age-related bone loss. The enzyme11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) increases local cortisol production, is expressed in human osteoblasts and its activity increases with age leading to a decrease in bone formation. We hypothesised that sele...

ea0032p870 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Incidental haemorrhage in prolactinomas: is it of any clinical significance?

Sarwar Komil , Huda Bobby , Van-de-Velde Vanessa , Hopkins Laura , Luck Sara , Preston Rebecca , McGowan Barbara , Carroll Paul , Powrie Jake

Background: Incidental pituitary haemorrhage in prolactinomas is a common radiological finding. The clinical significance, associations and outcome of this are largely unknown. Most reports describe surgically treated macroprolactinoma and non-functioning adenoma, and there are few data in a clinic prolactinoma population.Aims: To characterise the prevalence, natural history and risk factors associated with pituitary haemorrhage in a large clinic prolact...

ea0031p260 | Pituitary | SFEBES2013

Incidental pituitary haemorrhage is common in prolactin-secreting macroadenoma especially in women

Sarwar Komil , Huda Bobby , Van de Velde Vanessa , Hopkins Laura , Luck Sara , Preston Rebecca , McGowan Barbara , Carroll Paul , Powrie Jake

Background: Incidental pituitary haemorrhage, not associated with pituitary apoplexy, is a common clinical and radiological finding. Little information exists on the clinical behaviour of incidental haemorrhage with most reports describing surgically treated macroprolactinoma and non-functioning adenoma, and there are few data in a clinic prolactinoma population.Aims: To characterise the prevalence, natural history and risk factors associated with pituit...

ea0023oc2.1 | Oral Communications 2 | BSPED2009

Final height in Turner syndrome after Oxandrolone and delayed pubertal induction: results of a UK randomised, double-blind, placebo-controlled trial

Gault Emma-Jane , Perry Rebecca , Casey Sarah , Cole Tim , Paterson Wendy , Hindmarsh Peter , Betts Peter , Dunger David , Donaldson Malcolm

The UK Turner Study examined in girls with Turner syndrome (TS) the impact on final height (FH) of Oxandrolone (Ox) and/or delayed pubertal induction (14y).Methods: Girls with TS aged 7–13y receiving GH were randomised to Ox (0.05 mg/kg per day, max. dose 2.5 mg/day) or placebo from 9y (or from enrolment if >9y). Girls requiring oestrogen were further randomised to begin oral Ethinylestradiol (E2) (Y1:2 μg/day; Y2:4 μg/day; ...

ea0045oc9.1 | Oral Communications 9- Nurses | BSPED2016

A review of junior doctors’ knowledge of the management of newborn disorders of sexual development

Alsaffar Hussain , Turner Lucy , Odedun Rebecca , Giri Dinesh , Edwards Zoe , Blair Jo , Kenny Simon , Senniappan Senthil , McAndrew Fiona , Das Urmi

Introduction: Disorders of sexual development (DSDs) are estimated to occur in 1 in 4500 births. This potentially represents one baby born every other day in the UK. We aim to explore how Mersey foundation and paediatric trainees deal with newborn babies with possible DSD and identify if there is a need for further training in this subject.Methods: An online survey composed of 10 questions was distributed amongst foundation and paediatric trainees in Mer...

ea0092ps2-20-06 | Thyroid hormone receptors basic | ETA2023

A cardiac developmental defect prevents thyroid hormone-induced tachycardia in the syndrome of resistance to thyroid hormone alpha

Dore Riccardo , Christine Sentis Sarah , Oelkrug Rebecca , Krause Christin , Geiszler Cathleen , Pedaran Mehdi , Kirchner Henriette , Mittag Jens

Objectives: Thyroid hormones (TH) affect cardiovascular functions via direct actions on the heart and via indirect actions on central nervous system. Mutations in TH receptor α1 (TRα1) cause Resistance to Thyroid Hormone α (RTHα), a disorder characterized by hypothyroidism in TRα1-expressing tissues including the heart.Methods: The current experiments aimed at investigating the role of peripheral and central TR&...

ea0094p337 | Endocrine Cancer and Late Effects | SFEBES2023

Pilot study of liquid biopsy in paragangliomas: a feasible alternative to tissue biopsy in inoperable and multifocal lesions?

White Gemma , Quinn Mark , Carroll Paul , Velusamy Anand , Thakali Sonu , J. Oakey Rebecca , Izatt Louise , Hassan Fahim-UI

Background: Phaeochromocytoma and paraganglioma (PPGL) are highly heritable, with 30-40% due to a germline pathogenic variant. An additional 40% of tumours will harbour a somatic variant. Understanding the variant status of a tumour enables molecular classification. Liquid biopsy offers a novel approach to non-invasive diagnostics by harnessing the ability to detect small amounts of circulating-free DNA (cfDNA) and performing genomic sequencing. There are few ...